Literature DB >> 20213498

The ApoB/ApoA1 ratio is associated with metabolic syndrome and its components in a Chinese population.

Li Zhong1, Qifu Li, Yuanjuan Jiang, Dan Cheng, Zhoujun Liu, Bangqiong Wang, Rong Luo, Qingfeng Cheng, Hua Qing.   

Abstract

In this study, we assessed whether the apolipoprotein B/apolipoprotein A1 ratio (ApoB/ApoA1) is related to metabolic syndrome (MS) and its components in an urban Chinese population. A total of 709 community residents were enrolled. Metabolic syndrome was defined according to the International Diabetes Federation definition in 2005. The high ApoB/ApoA1 group was defined as the gender-specific upper quartile of the ApoB/ApoA1 ratio. Insulin resistance (IR) was defined as the upper quartile of Homa-IR. The ApoB/ApoA1 ratio was significantly higher in subjects with MS, compared to those without (p < 0.05). After adjusting for age and gender, subjects with MS (odds ratio [OR] = 3.5) or IR (OR = 2.3) were more likely to be in the high ApoB/ApoA1 group. The ApoB/ApoA1 ratio increased significantly as the number of MS components increased (p < 0.05). Taken together, these data demonstrate that the ApoB/ApoA1 ratio is strongly associated with MS and its components in an urban Chinese population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20213498     DOI: 10.1007/s10753-010-9193-4

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  18 in total

1.  The metabolic syndrome--a new worldwide definition.

Authors:  K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

2.  Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.

Authors:  Christa Meisinger; Hannelore Loewel; Wilfried Mraz; Wolfgang Koenig
Journal:  Eur Heart J       Date:  2004-11-30       Impact factor: 29.983

3.  High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

Authors:  G Walldius; I Jungner; I Holme; A H Aastveit; W Kolar; E Steiner
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

4.  The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.

Authors:  Lars Lind; Bengt Vessby; Johan Sundström
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-11-23       Impact factor: 8.311

5.  [Epidemiologic characteristics of dyslipidemia in people aged 18 years and over in China].

Authors:  Wen-hua Zhao; Jian Zhang; Yue You; Qing-qing Man; Hong Li; Chun-rong Wang; Yi Zhai; Ying Li; Shui-gao Jin; Xiao-guang Yang
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2005-09

6.  ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.

Authors:  Justo Sierra-Johnson; Abel Romero-Corral; Virend K Somers; Francisco Lopez-Jimenez; Göran Walldius; Anders Hamsten; Mai-Lis Hellénius; Rachel M Fisher
Journal:  Eur Heart J       Date:  2007-09-01       Impact factor: 29.983

7.  The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.

Authors:  Göran Walldius; Ingmar Jungner; Are H Aastveit; Ingar Holme; Curt D Furberg; Allan D Sniderman
Journal:  Clin Chem Lab Med       Date:  2004       Impact factor: 3.694

8.  Relationships of apolipoprotein B(100) with the metabolic syndrome in Type 2 diabetes mellitus.

Authors:  F Relimpio; F Losada; A Pumar; M A Mangas; F Morales; R Astorga
Journal:  Diabetes Res Clin Pract       Date:  2002-09       Impact factor: 5.602

9.  Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM).

Authors:  Kristina Dunder; Lars Lind; Björn Zethelius; Lars Berglund; Hans Lithell
Journal:  Am Heart J       Date:  2004-10       Impact factor: 4.749

10.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

View more
  8 in total

1.  Determinants of ApoB, ApoA1, and the ApoB/ApoA1 ratio in healthy schoolgirls, prospectively studied from mean ages 10 to 19 years: the Cincinnati National Growth and Health Study.

Authors:  John A Morrison; Charles J Glueck; Stephen R Daniels; Paul S Horn; Ping Wang
Journal:  Metabolism       Date:  2012-04-16       Impact factor: 8.694

2.  Case-Control Study to Investigate the Association Between Serum Apolipoprotein B/A1 Ratio and Atrial Fibrillation by Sex in 920 Patients from China.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng; Mengqi Yang
Journal:  Med Sci Monit       Date:  2022-05-14

3.  Predictive value of serum apolipoprotein B/apolipoprotein A-I ratio in metabolic syndrome risk: a Chinese cohort study.

Authors:  Yu-Ching Chou; Jen-Chun Kuan; Chyi-Huey Bai; Tsan Yang; Wan-Yun Chou; Po-Chien Hsieh; San-Lin You; Lee-Ching Hwang; Chien-Hua Chen; Cheng-Yu Wei; Chien-An Sun
Journal:  Endocrine       Date:  2014-10-12       Impact factor: 3.633

4.  The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults.

Authors:  Laura A Da Costa; Paul Arora; Bibiana García-Bailo; Mohamed Karmali; Ahmed El-Sohemy; Alaa Badawi
Journal:  Diabetes Metab Syndr Obes       Date:  2012-10-04       Impact factor: 3.168

5.  Obesity contributes more to increasing ApoB/ApoA1 ratio than hyperandrogenism in PCOS women aged 20-38 years in China.

Authors:  Jianhua Zheng; Qianqian Yin; Juanyi Cao; Bei Zhang
Journal:  Exp Ther Med       Date:  2017-01-31       Impact factor: 2.447

6.  The value of Apolipoprotein B/Apolipoprotein A1 ratio for metabolic syndrome diagnosis in a Chinese population: a cross-sectional study.

Authors:  Fangyuan Jing; Yingying Mao; Jing Guo; Zhenyu Zhang; Yingjun Li; Zhenhua Ye; Ye Ding; Jianbing Wang; Mingjuan Jin; Kun Chen
Journal:  Lipids Health Dis       Date:  2014-05-14       Impact factor: 3.876

7.  Serum apolipoprotein B/apolipoprotein A1 ratio in relation to intervertebral disk herniation: a cross-sectional frequency-matched case-control study.

Authors:  Fei Chen; Tongde Wu; Chong Bai; Song Guo; Wenjun Huang; Yaqin Pan; Huiying Zhang; Desheng Wu; Qiang Fu; Qi Chen; Xinhua Li; Lijun Li
Journal:  Lipids Health Dis       Date:  2021-07-29       Impact factor: 4.315

8.  Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation.

Authors:  Xunwei Deng; Jingyuan Hou; Qiaoting Deng; Zhixiong Zhong
Journal:  Lipids Health Dis       Date:  2021-09-29       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.